Kardigan, Inc. (KARD) stock
KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$13.19+0.34 (+2.65%)
Close on Nov 17, 2026Market cap $1.23BP/E –Yield –
Kardigan ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$63.16M | – |
| Q3 FY2025 | Sep 30, 2025 | -$57.84M | – |
See a number that looks wrong?